 Premal Trivedi
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Portasystemic Shunt, Transjugular Intrahepatic | 7 | 2025 | 38 | 3.490 |
Why?
| | Vena Cava Filters | 8 | 2025 | 64 | 2.850 |
Why?
| | Ischemic Attack, Transient | 4 | 2023 | 71 | 2.680 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 36 | 2.490 |
Why?
| | Hepatorenal Syndrome | 3 | 2025 | 15 | 2.420 |
Why?
| | Radiology, Interventional | 4 | 2024 | 49 | 2.370 |
Why?
| | Renal Replacement Therapy | 2 | 2025 | 100 | 1.730 |
Why?
| | Radiography, Interventional | 2 | 2025 | 130 | 1.650 |
Why?
| | Liver Transplantation | 3 | 2025 | 823 | 1.550 |
Why?
| | Medicare | 9 | 2025 | 887 | 1.500 |
Why?
| | Radiology | 3 | 2023 | 175 | 1.400 |
Why?
| | Neuroimaging | 3 | 2026 | 292 | 1.240 |
Why?
| | Cholestasis | 2 | 2023 | 219 | 1.160 |
Why?
| | Stroke | 3 | 2023 | 1258 | 1.160 |
Why?
| | Device Removal | 3 | 2025 | 143 | 1.160 |
Why?
| | Practice Patterns, Physicians' | 6 | 2021 | 1358 | 1.140 |
Why?
| | Hyperaldosteronism | 2 | 2025 | 12 | 1.020 |
Why?
| | Gastrointestinal Hemorrhage | 3 | 2021 | 136 | 0.940 |
Why?
| | Pulmonary Embolism | 4 | 2021 | 244 | 0.900 |
Why?
| | United States | 24 | 2025 | 15988 | 0.890 |
Why?
| | Renal Dialysis | 2 | 2020 | 462 | 0.880 |
Why?
| | Peripheral Arterial Disease | 2 | 2022 | 503 | 0.840 |
Why?
| | Emergency Service, Hospital | 5 | 2026 | 2313 | 0.780 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2022 | 237 | 0.770 |
Why?
| | Treatment Outcome | 15 | 2026 | 11695 | 0.720 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2026 | 372 | 0.690 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 94 | 0.690 |
Why?
| | Biliary Tract Surgical Procedures | 1 | 2021 | 28 | 0.650 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2021 | 89 | 0.620 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 94 | 0.610 |
Why?
| | Retrospective Studies | 17 | 2026 | 17101 | 0.610 |
Why?
| | Healthcare Disparities | 2 | 2026 | 728 | 0.600 |
Why?
| | Specialization | 1 | 2020 | 136 | 0.580 |
Why?
| | Medicine | 1 | 2020 | 125 | 0.570 |
Why?
| | Liver Neoplasms | 2 | 2026 | 783 | 0.560 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 19 | 0.540 |
Why?
| | Humans | 42 | 2026 | 144957 | 0.530 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 42 | 0.530 |
Why?
| | Leptin | 2 | 2008 | 245 | 0.490 |
Why?
| | Aged, 80 and over | 10 | 2026 | 8279 | 0.490 |
Why?
| | Ascites | 1 | 2016 | 49 | 0.470 |
Why?
| | Lower Extremity | 1 | 2020 | 438 | 0.460 |
Why?
| | Hypertension, Portal | 1 | 2016 | 66 | 0.450 |
Why?
| | Logistic Models | 5 | 2021 | 2119 | 0.440 |
Why?
| | Endovascular Procedures | 1 | 2020 | 384 | 0.440 |
Why?
| | Intracranial Hypotension | 2 | 2026 | 62 | 0.430 |
Why?
| | Aged | 16 | 2026 | 25947 | 0.420 |
Why?
| | Adrenal Glands | 2 | 2025 | 77 | 0.420 |
Why?
| | Databases, Factual | 6 | 2022 | 1486 | 0.370 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1563 | 0.360 |
Why?
| | Radiography | 3 | 2023 | 845 | 0.350 |
Why?
| | Catheterization | 2 | 2023 | 183 | 0.340 |
Why?
| | Constriction, Pathologic | 2 | 2023 | 248 | 0.330 |
Why?
| | Patient Discharge | 3 | 2022 | 983 | 0.320 |
Why?
| | Risk Factors | 6 | 2025 | 10792 | 0.320 |
Why?
| | Male | 20 | 2026 | 72406 | 0.310 |
Why?
| | Hemodynamics | 2 | 2025 | 1121 | 0.310 |
Why?
| | Predictive Value of Tests | 2 | 2025 | 2118 | 0.310 |
Why?
| | Apoptosis | 2 | 2008 | 2430 | 0.300 |
Why?
| | Female | 19 | 2026 | 78376 | 0.270 |
Why?
| | Middle Aged | 13 | 2026 | 35928 | 0.270 |
Why?
| | Muscle Cells | 1 | 2007 | 42 | 0.260 |
Why?
| | Neoplasms | 1 | 2023 | 2884 | 0.260 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5872 | 0.250 |
Why?
| | Cardiomegaly | 1 | 2007 | 174 | 0.240 |
Why?
| | Cosyntropin | 1 | 2025 | 7 | 0.230 |
Why?
| | Yttrium Radioisotopes | 1 | 2026 | 64 | 0.230 |
Why?
| | Goldenhar Syndrome | 1 | 2025 | 11 | 0.230 |
Why?
| | Cohort Studies | 5 | 2026 | 5965 | 0.230 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 381 | 0.230 |
Why?
| | Cranial Fossa, Middle | 1 | 2025 | 19 | 0.230 |
Why?
| | Fistula | 1 | 2025 | 48 | 0.220 |
Why?
| | Hospitals | 2 | 2021 | 732 | 0.220 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 556 | 0.200 |
Why?
| | Adult | 11 | 2026 | 40506 | 0.200 |
Why?
| | Biomarkers | 2 | 2025 | 4275 | 0.200 |
Why?
| | Aldosterone | 1 | 2023 | 43 | 0.200 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2925 | 0.190 |
Why?
| | Gallbladder Diseases | 1 | 2022 | 11 | 0.190 |
Why?
| | Watchful Waiting | 1 | 2023 | 89 | 0.180 |
Why?
| | Atherectomy | 1 | 2022 | 37 | 0.180 |
Why?
| | Forecasting | 1 | 2024 | 391 | 0.180 |
Why?
| | Socioeconomic Factors | 2 | 2026 | 1327 | 0.180 |
Why?
| | Hospitalization | 3 | 2021 | 2434 | 0.170 |
Why?
| | Cholecystostomy | 1 | 2021 | 3 | 0.170 |
Why?
| | Cholecystitis, Acute | 1 | 2021 | 24 | 0.170 |
Why?
| | Femoral Artery | 1 | 2022 | 190 | 0.170 |
Why?
| | Cholecystectomy | 1 | 2021 | 59 | 0.170 |
Why?
| | Vena Cava, Inferior | 1 | 2021 | 81 | 0.160 |
Why?
| | Oropharynx | 1 | 2020 | 46 | 0.160 |
Why?
| | Mouth | 1 | 2020 | 88 | 0.160 |
Why?
| | Larynx | 1 | 2020 | 56 | 0.160 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 28 | 0.160 |
Why?
| | Cardiologists | 1 | 2020 | 47 | 0.150 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 220 | 0.150 |
Why?
| | Radiologists | 1 | 2020 | 61 | 0.150 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 80 | 0.150 |
Why?
| | Time Factors | 3 | 2020 | 7183 | 0.140 |
Why?
| | Odds Ratio | 1 | 2021 | 1077 | 0.140 |
Why?
| | Recurrence | 1 | 2021 | 1135 | 0.140 |
Why?
| | Acute Disease | 1 | 2021 | 1031 | 0.140 |
Why?
| | Hemorrhage | 1 | 2023 | 809 | 0.140 |
Why?
| | Inpatients | 2 | 2019 | 546 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 636 | 0.130 |
Why?
| | Vascular Patency | 1 | 2018 | 121 | 0.130 |
Why?
| | Health Services Accessibility | 1 | 2026 | 1099 | 0.130 |
Why?
| | Liver Cirrhosis | 1 | 2019 | 288 | 0.130 |
Why?
| | Radiology Department, Hospital | 1 | 2017 | 16 | 0.130 |
Why?
| | Prosthesis Implantation | 1 | 2018 | 153 | 0.130 |
Why?
| | Linear Models | 2 | 2017 | 854 | 0.130 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 73 | 0.130 |
Why?
| | Venous Thromboembolism | 2 | 2018 | 324 | 0.130 |
Why?
| | Adolescent | 6 | 2021 | 22453 | 0.120 |
Why?
| | Drug Utilization | 1 | 2017 | 167 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 2 | 2025 | 2738 | 0.120 |
Why?
| | Cardiovascular Diseases | 1 | 2008 | 2171 | 0.120 |
Why?
| | Inservice Training | 1 | 2017 | 117 | 0.120 |
Why?
| | Personnel Selection | 1 | 2017 | 93 | 0.120 |
Why?
| | Surgeons | 1 | 2020 | 340 | 0.110 |
Why?
| | Obesity | 1 | 2008 | 3082 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2020 | 603 | 0.110 |
Why?
| | Hospital Mortality | 2 | 2018 | 1031 | 0.110 |
Why?
| | Comorbidity | 2 | 2018 | 1660 | 0.110 |
Why?
| | Prevalence | 1 | 2021 | 2836 | 0.100 |
Why?
| | Faculty, Medical | 1 | 2017 | 303 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1182 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2947 | 0.090 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1540 | 0.090 |
Why?
| | Anticoagulants | 1 | 2017 | 724 | 0.090 |
Why?
| | Sex Factors | 1 | 2018 | 2114 | 0.090 |
Why?
| | Young Adult | 4 | 2021 | 14126 | 0.090 |
Why?
| | Internship and Residency | 1 | 2022 | 1257 | 0.090 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5417 | 0.080 |
Why?
| | Brain | 1 | 2023 | 2941 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3869 | 0.080 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2022 | 162 | 0.080 |
Why?
| | Heart Failure | 2 | 2018 | 2323 | 0.080 |
Why?
| | Length of Stay | 1 | 2016 | 1337 | 0.080 |
Why?
| | Positron-Emission Tomography | 2 | 2022 | 343 | 0.080 |
Why?
| | Survival Rate | 2 | 2018 | 2092 | 0.070 |
Why?
| | Rats, Zucker | 1 | 2008 | 32 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2642 | 0.070 |
Why?
| | Mice, Obese | 1 | 2007 | 66 | 0.070 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2007 | 109 | 0.060 |
Why?
| | Caspase 3 | 1 | 2007 | 238 | 0.060 |
Why?
| | Catalysis | 1 | 2007 | 322 | 0.060 |
Why?
| | Single Photon Emission Computed Tomography Computed Tomography | 1 | 2026 | 15 | 0.060 |
Why?
| | Intracranial Pressure | 1 | 2006 | 65 | 0.060 |
Why?
| | Adrenalectomy | 1 | 2025 | 71 | 0.060 |
Why?
| | Microspheres | 1 | 2026 | 142 | 0.060 |
Why?
| | Veins | 1 | 2025 | 68 | 0.060 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2026 | 71 | 0.060 |
Why?
| | Headache | 1 | 2026 | 150 | 0.050 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1141 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2025 | 423 | 0.050 |
Why?
| | Cholangiocarcinoma | 1 | 2026 | 106 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1990 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2008 | 2540 | 0.050 |
Why?
| | Myocardium | 1 | 2007 | 939 | 0.050 |
Why?
| | Interdisciplinary Research | 1 | 2022 | 26 | 0.050 |
Why?
| | Gallbladder | 1 | 2021 | 15 | 0.040 |
Why?
| | Radiopharmaceuticals | 1 | 2022 | 207 | 0.040 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2022 | 117 | 0.040 |
Why?
| | Brain Injuries | 1 | 2006 | 508 | 0.040 |
Why?
| | Laryngeal Neoplasms | 1 | 2020 | 35 | 0.040 |
Why?
| | Insulin Resistance | 1 | 2008 | 1241 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 489 | 0.040 |
Why?
| | Rats | 1 | 2008 | 5614 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2020 | 769 | 0.040 |
Why?
| | Hospital Bed Capacity | 1 | 2018 | 28 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2018 | 119 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2008 | 4569 | 0.030 |
Why?
| | Hospitals, Urban | 1 | 2018 | 144 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 205 | 0.030 |
Why?
| | Colorado | 1 | 2026 | 4564 | 0.030 |
Why?
| | Animals | 2 | 2008 | 38109 | 0.030 |
Why?
| | Signal Transduction | 1 | 2008 | 5233 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 359 | 0.030 |
Why?
| | Career Choice | 1 | 2017 | 237 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1268 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 557 | 0.030 |
Why?
| | Age Factors | 1 | 2018 | 3335 | 0.020 |
Why?
| | Mice | 1 | 2007 | 18365 | 0.020 |
Why?
| | Curriculum | 1 | 2017 | 1060 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3192 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7997 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 6053 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2006 | 112 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 2006 | 213 | 0.010 |
Why?
| | Observer Variation | 1 | 2006 | 355 | 0.010 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2006 | 285 | 0.010 |
Why?
| | Child | 2 | 2017 | 22657 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11799 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3415 | 0.010 |
Why?
|
|
Trivedi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|